IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 83 filers reported holding IMMUNOMEDICS INC in Q3 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $480,000 | +31.5% | 25,000 | 0.0% | 0.03% | +57.9% |
Q1 2018 | $365,000 | -67.8% | 25,000 | -64.3% | 0.02% | -63.5% |
Q4 2017 | $1,132,000 | +101.4% | 70,000 | -49.4% | 0.05% | +372.7% |
Q2 2015 | $562,000 | -57.6% | 138,400 | -60.0% | 0.01% | -59.3% |
Q1 2015 | $1,325,000 | – | 346,090 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 4,750,000 | $112,433,000 | 20.02% |
Avoro Capital Advisors LLC | 17,714,461 | $419,301,000 | 16.14% |
Foresite Capital Management III, LLC | 2,541,729 | $60,163,000 | 12.96% |
Foresite Capital Management IV, LLC | 1,231,543 | $29,151,000 | 9.94% |
Ghost Tree Capital, LLC | 1,250,000 | $29,588,000 | 8.71% |
NEXTHERA CAPITAL LP | 1,329,104 | $31,460,000 | 4.87% |
RA Capital Management | 3,119,778 | $73,845,000 | 4.79% |
DLD Asset Management, LP | 2,682,100 | $63,458,000 | 4.78% |
Palo Alto Investors LP | 4,803,364 | $113,696,000 | 4.54% |
DLD Asset Management, LP | 2,411,600 | $57,058,000 | 4.30% |